High-Dimensional Fixed Effects Profiling Models and Applications in End-Stage Kidney Disease Patients: Current State and Future Directions

Author:

Nguyen Danh V.,Qian Qi,You Amy S.,Kurum Esra,Rhee Connie M.,Senturk Damla

Abstract

Profiling analysis aims to evaluate health care providers, including hospitals, nursing homes, or dialysis facilities among others with respect to a patient outcome, such as 30-day unplanned hospital readmission or mortality. Fixed effects (FE) profiling models have been developed over the last decade, motivated by the overall need to (a) improve accurate identification or “flagging” of under-performing providers, (b) relax assumptions inherent in random effects (RE) profiling models, and (c) take into consideration the unique disease characteristics and care/treatment processes of end-stage kidney disease (ESKD) patients on dialysis. In this paper, we review the current state of FE methodologies and their rationale in the ESKD population and illustrate applications in four key areas: profiling dialysis facilities for (1) patient hospitalizations over time (longitudinally) using standardized dynamic readmission ratio (SDRR), (2) identification of dialysis facility characteristics (e.g., staffing level) that contribute to hospital readmission, and (3) adverse recurrent events using standardized event ratio (SER). Also, we examine the operating characteristics with a focus on FE profiling models. Throughout these areas of applications to the ESKD population, we identify challenges for future research in both methodology and clinical studies.

Publisher

Lifescience Global

Subject

Health Information Management,Health Informatics,Health Professions (miscellaneous),Statistics and Probability

Reference76 articles.

1. United States Renal Data System. USRDS 2022Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available fromhttps://adr.usrds.org/2022.

2. United States Renal Data System. USRDS 2020 Annual Data Report: Epidemiology of Kidney Disease and in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. [cited 2020]: Available from https://adr.usrds.org/2020.

3. Kalantar-Zadeh K, Kovesdy CP, Streja E, Rhee MC, Soohoo M, Chen JLT, Molnar MZ, Gillen D, Nguyen DV, Norris KC, Sim JJ, Jacobsen SS Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transplant 2017; 32(suppl_2): ii91-ii98. https://doi.org/10.1093/ndt/gfw357

4. United States Renal Data System. USRDS 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.

5. Soohoo M, Streja E, Obi Y, Rhee CM, Gillen DL, Sumida K, Nguyen DV, Kovesdy CP, Kalantar-Zadeh K. Predialysis kidney function and its rate of decline predict mortality and hospitalization after starting dialysis. Mayo Clinic Proceedings 2018; 93(8): 1074-1085. https://doi.org/10.1016/j.mayocp.2018.01.030

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3